6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
1h ago	Regency Silver Appoints Private Equity Fund Manager Alejandro Sucre to Board of Directors
1h ago	Entrepreneur Universe Bright Group Reports First Quarter 2026 Financial Results
2h ago	Rio2 Reports First Quarter 2026 Financial Results and Operations Update
3h ago	Letter to the Shareholders
4h ago	ImagineAR Announces Non-Brokered Private Placement Financing

About

3.43SEK+0.02 +0.59%

Closed • Updated at 05:44 GMT+00:00

Market Cap$90.20M

P/E Ratio5.80

Volume1.69M

Beta0.59

RSI34.92

Gross Margin98.97%

Health TechnologyPharmaceuticals: Major

Cantargia Ab — investor relations, events, news, and company updates on 6ix.

Latest News

Cantargia Announces Early Results from Trial of Nadunolimab in MDS and AML

Notice of Annual General Meeting in Cantargia AB (publ)

Cantargia Publishes Annual Report 2025

Cantargia to Participate at Van Lanschot Kempen's Life Sciences Conference

Cantargia to Participate in TD Cowen's Annual Healthcare Conference

Recent Videos

How to Invest in Cantargia AB (CANTA.ST) Step by Step

How to Invest in Cantargia AB (CANTA.ST) Step by Step

Mar 15, 2026

CANTA STOCK : BIG PRICE RECOVERY | CANTARGIA STOCK

CANTA STOCK : BIG PRICE RECOVERY | CANTARGIA STOCK

Jan 13, 2026

Cantargia's Nadunolimab Antibody: FDA Fast Track Designation Explained

Cantargia's Nadunolimab Antibody: FDA Fast Track Designation Explained

Jun 15, 2025

BioStock Investor Pitch: Cantargia vill flytta fram positionerna

BioStock Investor Pitch: Cantargia vill flytta fram positionerna

Dec 13, 2024

Community Chat

Ask AI